SSIEM 2014 Golgi post - translational modifications and associated diseases Sven Potelle 1 & André Klein 2 & François Foulquier 1 Received : 16 February 2015 / Revised : 2 April 2015 / Accepted : 8 April 2015 / Published online : 13 May 2015 # SSIEM 2015 Abstract For non specialists , Golgi is a very well known sub - cellular compartment involved in secretion and correct targeting of soluble and transmembrane proteins . Nevertheless , Golgi is also specifically involved in many different and diverse post - translational modifications . Through its diverse functions , Golgi is not only able to modify secreted and transmembrane proteins but also cytoplasmic proteins . The Golgi apparatus research field is so broad that an exhaustive review of this organelle is not doable here . The goal of this review is to cover the main post - translational modifications occurring at the Golgi level and present the identified associated diseases . Golgi , a brief overview Golgi is a cellular organelle composed of several flattened stacks of membranes devoid of ribosomes . These stacks are functionally different and reflect the specific compartmentali - zation of Golgi enzymes / transporters involved in the modifi - cations of proteins and lipids . The GA stacks are classically delimited as cis , median , trans , and trans - Golgi network ( TGN ) ( Farquhar 1985 ; Dunphy and Rothman 1985 ) . Present in all animal cells and plants , Golgi is a part of a highly integrated and regulated endomembrane system ( Mollenhauer and Morré 1974 ) . Golgi constantly receives incoming material from the endoplasmic reticulum ( ER ) and sorts specific cargo to their correct cellular destination such as the endosomal - lysosomal compartments , the plasma membrane or extracel - lular space . The cargo movement through the stacks is still controversial and has been suggested to occur in vesicles , in maturing cisternae , or by tubular connections between cister - nae ( Glick and Luini 2011 ) . The overall Golgi structure and its plasticity are tightly controlled and crucial for maintaining its functions . As Golgi manufactures and modifies most of the cargo molecules passing through the different stacks , this or - ganelle is considered to be the main contributor to post - translational modifications ( PTM ) of lipids and proteins . In this review , we will mainly focus on Golgi PTM of proteins in which gene defects have been linked to human diseases . However , many others lead to Golgi PTM associated diseases without being directly involved in PTM . One can think that this last class will certainly constitute in the near future the next booming field of PTM associated diseases . PTM occuring at the Golgi level and associated diseases Glycosylation Glycosylation is a major post - translational 7modification of proteins and lipids . The main glycosylation types are classi - fied according to the linkage of the sugar moieties to the ami - no acid , asparagine ( N - glycosylation ) , serine or threonine ( O - glycosylation ) , and ceramide for glycolipids . Some of them begin directly in the ER lumen and continue at the Golgi level ( N - glycosylation , O - mannosylation , O - glucosylation , O - fucosylation , and glycolipids ) ( Fig . 1 ) . Nevertheless , certain Presented at the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism , Innsbruck , Austria , September 2 - 5 , 2014 Communicated by : Niels Gregersen Sven Potelle , André Klein and François Foulquier contributed equally to this work Article type : not Review but . * François Foulquier Francois . Foulquier @ univ - lille1 . fr 1 CNRS - UMR 8576 , Structural and Functional Glycobiology unit , FRABIO , University of Lille , 59655 Villeneuve d ’ Ascq , France 2 Centre de Biologie et Pathologies , UAM de glycopathologies , CHRU de Lille , University of Lille , 59000 Lille , France J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 DOI 10 . 1007 / s10545 - 015 - 9851 - 7 F i g . 1 P T M o c c u r i ng a t t h e G o l g i l e v e l . T h e r e p r e s e n t e d P T M s a r e t h e on e s i n w h i c h g e n e d e f ec t s li nk e d t o hu m a n p a t ho l og i e s h a v e b ee n f ound . E ac h P T M i s l o ca t e d on t h e s p ec i f i c G o l g i c i s t e r n ae acc o r d i ng t o t h e kno w n l o ca ti on . T h e ca s e o f s ug a r s u l f a ti on i s a littl e m o r e c o m p l e x . I nd ee d , s u l f a ti on o f h e p a r a n s u l f a t e i s a s e qu e n ti a l p r o ce ss ( N - s u l f a ti on , t h e n 2 - O , 6 - O , a nd f i n a ll y 3 - O s u l f a ti on ) t a k i ng p l ace a t t h e G o l g i l e v e l bu t t h e e n z y m e s a r e no t c l ea r l y l o ca li ze d s o f a r . XD P / X M P : N u c l e o ti d e d i / m ono pho s ph a t e . ND S T : N - d eace t y l a s e / N - s u l f o t r a n s f e r a s e ; T PS T : T y r o s y l p r o t e i n s u l f o t r a n s f e r a s e . UD P / U M P : U r i d i n e d i / m onopho s ph a t e . F G F 23 : f i b r ob l a s t g r o w t h f ac t o r 23 . P R M T 5 : p r o t e i n a r g i n i n e m e t hy lt r a n s f e r a s e 5 . S A M : S - a d e no s y l m e t h i on i n e . S R E B P : s t e r o l r e gu l a t o r y e l e m e n t - b i nd i ngp r o t e i n s 742 J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 types are entirely performed at the Golgi level ( O - N - acetylgalactosaminylation ( mucin types ) and O - xylosylation ( glycosaminoglycans ) ) . Golgi glycosylation mainly consists in the elongation of the sugar chain ( s ) by addition of specific sugars such as galactose , N - acetylglucosamine , N - acetylgalactosamine , fucose , sialic acids etc . N - glycosylation is an exception to this process where before further elongation , mannose removal might occur , a process extremely well doc - umented in several reviews ( Roth 2002 ; Roth et al 2010 ; Stanley 2011 ) . The sugar additions at the Golgi level rely on the existence of specific nucleotide sugar transporters and specific Golgi enzymes named glycosyltransferases ( GT ) . Defects in these genes have been first identified in human diseases called CDG for congenital disorders of glycosylation ( Jaeken and Matthijs 2001 ) . Nevertheless , a constantly growing subgroup of CDG indirectly affects glycosylation pathways through alterations of Golgi structure , vesicular trafficking and Golgi homeosta - sis . Today , more than 110 different CDGs have been reported ( Freeze et al 2014 ) and approximately a third of them disturbs Golgi glycosylation ( Jaeken 2011 ) . The identification of these patients was performed via the main screening diagnostic test based on transferrin isoelectrofocalisation pattern , although this test only detects patients with N - glycosylation defects ( Hackler et al 2000 ; Carchon et al 2006 ) . Defects in genes directly involved in glycosylation Given the excellent recent reviews about CDGs , this part will only describe the identified CDGs from the last two years ( Jaeken 2011 ; Hennet 2012 ; Cylwik et al 2013a , b ; Rosnoblet et al 2013 ; Freeze 2013 ; Krasnewich 2014 ; Freeze et al 2014 ; Scott et al 2014 ) . Four new CDGs directly affecting Golgi glycosylation have been identified : MAN1B1 - CDG ( Rymen et al 2013 ) , SLC35A1 - CDG ( Mohamed et al 2013 ; Riemersma et al 2014 ) , SLC35A2 - CDG ( Ng et al 2013 ; Kodera et al 2013 ) , and SLC35A3 - CDG . The clinical pheno - types of these pathologies are summarized in Table 1 . MAN1B1 is presumed ( still controversial ) to be a Golgi α 1 , 2 mannosidase involved in the processing of the terminal mannose residues . The clinic is classically mild with observed mental retardation associated with slight facial dysmorphism , and truncal obesity ( Rymen et al 2013 ) . However , some pa - tients also show more serious phenotypes , including severe intellectual disabilities and a global developmental delay ( Van Scherpenzeel et al 2014 ) . Three other deficiencies affecting sugar nucleotide trans - porters were also recently identified . Alterations of SLC35A1 , which is the CMP - sialic acid transporter , leads to an autoso - mal recessive disorder characterized by seizures , ataxia , intel - lectual disabilities , multiple bleeding episodes , and recurrent infections ( Mohamed et al 2013 ) . Similarly , defects in SLC35A2 , an X - linked disorder , affect the UDP - galactose transporter . The patients also present intellectual disabilities and seizures and in some cases , ocular and skeletal abnormal - ities ( Ng et al 2013 ) . Recently , defects in SLC35A3 , the main UDP - N - acetylglucosamine transporter , have been linked to a syndrome characterized by arthrogryposis , mental retardation , and seizures ( AMRS ) ( Edvardson et al 2013 ) . All these trans - porter deficiencies affect the Golgi luminal pool of nucleotide sugars and consequently different glycosylation pathways . This might explain the severity of the observed phenotypes ( Table 1 ) . Defects in genes indirectly involved in glycosylation : de - fects in vesicular transport There are more than a hundred genes involved indirectly in PTM . These genes can either be responsible for the structure , the organization and the homeostasis of the Golgi apparatus , or can also mediate the intracellular destination of vesicular transport . The defect of the Golgi function results in abnormal transport of cargo molecules and / or defective PTM . In this chapter , we will describe some examples of diseases in which the gene defect has consequences on the PTM , with a partic - ular focus on glycosylation . The lack of assay exploring the different PTM as well as the unavailability of the tissues for clinical testing ( i . e . , nervous system ) make the biochemical diagnosis of this group of disorders quite difficult . In a great number of diseases only the genetic diagnosis is indeed avail - able and the potential alteration of the PTM has not been studied so far . COG complex In 2004 , the discovery of the COG7 deficient CDG patients opened a completely new molecular mechanisms of Golgi glycosylation defects ( Wu et al 2004b ; Ng et al 2007 ) . For the first time , the field of vesicular trafficking was connected to Golgi glycosylation . COG is indeed a multimeric cytoplas - mic complex of eight subunits ( Cog1 to Cog8 ) known to be involved in the tethering of vesicles to the target compart - ments such as Golgi . Since 2004 , many COG deficient CDG patients have been discovered and detailed in several reviews ( Foulquier 2009 ; Reynders et al 2011 ; Miller and Ungar 2012 ) . To date and except for the Cog3 subunit , mutations in all Cog subunits have been described responsible for CDGs ( Wu et al 2004b ; Foulquier et al 2006 , 2007 ; Kranz et al 2007 ; Reynders et al 2009 ; Paesold - Burda et al 2009 ; Lübbehusen et al 2010 ) . The recently identified COG defect was in Cog2 , and as for the other COG deficient CDG pa - tients , both N - and O - mucin type glycosylation defects were observed . The clinical manifestations are broad including mi - crocephaly , developmental delay , intellectual disability , sei - zures , facial dysmorphism , and liver dysfunctions ( Kodera et al 2014 ) . J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 743 T a b l e 1 G o l g i P T M s a nd a ss o c i a t e d d i s ea s e s . T h i s t a b l e s u mm a r i ze s a ll t h e hu m a n d i s o r d e r s li nk e d t o G o l g i P T M s p r e s e n t e d i n t h i s r e v i e w A ff ec t e d g e n e P r o t e i n A ff ec t e d P T M D i s ea s e M a j o r c li n i ca l m a n i f e s t a ti on s G e n e O M I M e n t r y D i s ea s e O M I M e n t r y M A N 1 B 1 α 1 , 2 m a nno s i d a s e g l y c o s y l a ti on M AN 1 B 1 - C DG s e v e r e m e n t a l r e t a r d a ti on , d e l a y e d s p eec h 604346 614202 S L C 35 A 1 C M P - s i a li c ac i d t r a n s po r t e r g l y c o s y l a ti on S L C 35 A 1 - C DG s e i z u r e s , i n t e ll ec t u a l d i s a b ilit y , a t a x i a , b l ee d i ng 605634 603585 S L C 35 A 2 UD P - g a l ac t o s e t r a n s po r t e r g l y c o s y l a ti on S L C 35 A 2 - C DG i n t e ll ec t u a l d i s a b ilit y , s e i z u r e s , s k e l e t a l a bno r m a liti e s 314375 300896 S L C 35 A 3 UD P - G l c NA c t r a n s po r t e r g l y c o s y l a ti on A r t h r og r ypo s i s , m e n t a l r e t a r d a ti on a nd s e i z u r e s a u ti s m s p ec t r u m d i s o r d e r , hypo t on i a , e p il e p s y , a nd a r t h r og r ypo s i s 605632 615553 S E C 23 B S ec 23 ho m o l og B g l y c o s y l a ti on D y s e r y t h r opo i e ti c a n e m i a , c ong e n it a l , t yp e II e r y t h r ob l a s ti c a n e m i a : s p l e no m e g a l y , g a ll s t on e s , a nd i r on ov e r l o a d po t e n ti a ll y w it h li v e r c i rr ho s i s o r ca r d i a c f a il u r e . 610512 224100 T R I P 11 G o l g i m i c r o t ubu l e a ss o c i a t e d p r o t e i n 210 g l y c o s y l a ti on A c hond r og e n e s i s t yp e 1 A s e v e r e c hond r ody s p l a s i a , l e t h a l b e f o r e o r s ho r tl y a f t e r b i r t h 604505 200600 U B E 3 A U b i qu iti n li g a s e E 3 A g l y c o s y l a ti on A ng e l m a n s ynd r o m e i n t e ll ec t u a l d i s a b ilit y , s e i z u r e s , l ac k o f s p eec h , a nd c h a r ac t e r i s ti c a bno r m a l b e h a v i o r 601623 105830 C O G 2 C o m pon e n t o f o li go m e r i c G o l g i c o m p l e x 2 g l y c o s y l a ti on C OG 2 - C DG m i c r o ce ph a l y , d e v e l op m e n t a l d e l a y , i n t e ll ec t u a l d i s a b ilit y , s e i z u r e s , f ac i a l dy s m o r ph i s m , li v e r dy s f un c ti on 606974 no e n t r y y e t S L C 33 A 1 S o l u t e ca rr i e r f a m il y 33 ( ace t y l - C o A t r a n s po r t e r ) , m e m b e r 1 ace t y l a ti on S p a s ti c p a r a p l e g i a - 42 s p a s ti c g a it , i n c r ea s e d l o w e r li m b t on e , w ea kn e ss a nd a t r ophy o f t h e l o w e r li m b m u s c l e s , p e s ca vu s 603690 612539 C H S T 3 C hond r o iti n 6 - O - s u l f o t r a n s f e r a s e s u l f a ti on S pondy l o - e p i phy s ea l dy s p l a s i a w it h j o i n t d i s l o ca ti on s unu s u a l s k e l e t a l dy s p l a s i a 603799 143095 C H S T 6 C o r n ea l N - ace t y l g l u c o s a m i n e - 6 - O - s u l f o t r a n s f e r a s e s u l f a ti on M ac u l a r c o r n ea l d i s t r ophy t yp e II p r og r e ss i v e c o r n ea l o p ac i f i ca ti on a nd r e du ce d c o r n ea l s e n s iti v it y 605294 217800 C H S T 8 G a l NA c - 4 - O s u l f o t r a n s f e r a s e I s u l f a ti on P ee li ng s k i n s ynd r o m e g e n e r a l s k i n p ee li ng 610190 270300 C H S T 14 D e r m a t a n s u l f a t e G a l NA c - 4 - O s u l f o t r a n s f e r a s e I s u l f a ti on E h l e r s - D a n l o s s ynd r o m e m u s c u l o c on t r ac t u r a l t yp e 1 c r a n i o f ac i a l dy s m o r p h i s m , c ong e n it a l c on t r ac t u r e s o f t hu m b s a nd f i n g e r s , c l ub f ee t , s e v e r e kypho s c o li o s i s 608429 601776 A R S E A r y l s u l f a t a s e E s u l f a ti on C hond r ody s p l a s i a pun c t a t a 1 s ti pp l e d e p i phy s e s , b r ac hy t e l e ph a l a ngy , n a s o m a x ill a r y hypop l a s i a 300180 302950 P A PPS 2 P A PS s yn t h a s e s u l f a ti on B r ac hyo l m i a t yp e 4 s ho r t - t r unk s t a t u r e , r ec t a ngu l a r v e r t e b r a l bod i e s , p r ec o c i ou s ca l c i f i ca ti on o f r i b ca r til a g e s , s ho r t f e m o r a l n ec k . E a r l y d ea t h f o r s e v e r e ca s e s . 603005 612847 S L A 26 A 2 S u l f a t e a n i on t r a n s po r t e r s u l f a ti on A c hond r og e n e s i s t yp e 1 B s e v e r e c hond r ody s p l a s i a , ea r l y d ea t h o f r e s p i r a t o r y f a il u r e 606718 600972 A t e l o s t e og e n e s i s t yp e 2 pu l m on a r y hypop l a s i a , l e t h a l i n i n f a n t s 606718 256050 E p i phy s ea l dy s p l a s i a m u lti p l e 4 j o i n t p a i n , s c o li o s i s , m a l f o r m a ti on s o f t h e h a nd s , f ee t , a nd kn ee s 606718 226900 D i a s t r oph i c dy s p l a s i a s c o li o s i s , c l ub f ee t , m a l f o r m e d p i nn ae w it h ca l c i f i ca ti on o f t h e ca r til a g e , c l e f t p a l a t e i n s o m e ca s e s 606718 222600 G N T P G N - ace t y l g l u c o s a m i n e - 1 - pho s pho t r a n s f e r a s e g a mm a s ubun it pho s pho r y l a ti on M u c o li p i do s i s III g a mm a s ho r t s t a t u r e , s k e l e t a l a bno r m a liti e s , ca r d i o m e g a l y , a nd d e v e l op m e n t a l d e l a y 607838 252605 744 J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 T a b l e 1 ( c on ti n u e d ) A ff ec t e d g e n e P r o t e i n A ff ec t e d P T M D i s ea s e M a j o r c li n i ca l m a n i f e s t a ti on s G e n e O M I M e n t r y D i s ea s e O M I M e n t r y GN T P A B N - ace t y l g l u c o s a m i n e - 1 - pho s pho t r a n s f e r a s e a l ph a a nd b e t a s ubun it s pho s pho r y l a ti on M u c o li p i do s i s II a nd III H i p d i s l o ca ti on , g i ng i v a l hyp e r p l a s i a n , t ho r ac i c d e f o r m iti e s a nd h e r n i a s oon a f t e r b i r t h . D e l a y e d p s y c ho m o t o r d e v e l op m e n t . S a m e c li n i ca l f ea t u r e s f o r m u c o li p i do s i s III a s d e s c r i b e d j u s t a b ov e . 607840 252500 252600 I M P A D 1 G o l g i - r e s i d e n t P A P pho s ph a t a s e pho s pho r y l a ti on C hond r ody s p l a s i a w it h j o i n t d i s l o ca ti on s s ho r t s t a t u r e , c hond r ody s p l a s i a w it h b r ac hyd ac t y l y , c ong e n it a l j o i n t d i s l o ca ti on s , m i c r ogn a t h i a , c l e f t p a l a t e , a nd f a c i a l dy s m o r ph i s m 614010 614078 I N PP 5 E I no s it o l po l ypho s ph a t e - 5 - pho s ph a t a s e pho s pho r y l a ti on M o r m s ynd r o m e M e n t a l r e t a r d a ti on , t r un ca l ob e s it y , r e ti n a l dy s t r ophy , a nd m i c r op e n i s 613037 610156 pho s pho r y l a ti on J oub e r t s ynd r o m e 1 H e t e r og e nou s : hypo p l a s i a o f t h e ce r e b e ll a r v e r m i s w it h t h e c h a r ac t e r i s ti c n e u r o r a d i o l og i c m o l a r t oo t h s i gn , dy s r e gu l a ti on o f b r ea t h i ng p a tt e r n a nd d e v e l op m e n t a l d e l a y . 613037 213300 A KA P 9 A - k i n a s e a n c ho r p r o t e i n 9 pho s pho r y l a ti on L ong Q T s ynd r o m e - 11 r ec u rr e n t s yn c op e , s e i z u r e , o r s udd e n d ea t h 604001 611820 F A M 20 C G o l g i k i n a s e ( f a m il y w it h s e qu e n ce s i m il a r it y 20 , m e m b e r C ) pho s pho r y l a ti on R a i n e s ynd r o m e n e on a t a l o s t e o s c l e r o ti c bon e dy s p l a s i a , i n c r ea s e d o ss i f i ca t i on o f t h e s ku ll 611061 259775 C A M K M T C a l m odu li n - l y s i n e N - m e t hy lt r a n s f e r a s e m e t hy l a ti on 2p21 d e l e ti on s ynd r o m e c y s ti nu r i a , n e on a t a l s e i z u r e s , hypo t on i a , s e v e r e s o m a ti c a nd d e v e l op m e n t a l d e l a y , f ac i a l dy s m o r ph i s m 609559 606407 M B T PS 2 S it e - 2 p r o t ea s e p r o t e o l y ti c c l ea v a g e I F A P s ynd r o m e w it h o r w it hou t BR E S H E C K s ynd r o m e i c h t hyo s i s f o lli c u l a r i s , a t r i c h i a , a nd pho t ophob i a 300294 308205 O l m s t e d s ynd r o m e , X - li nk e d p e r i o r i f i c i a l k e r a t o ti c p l a qu e s a nd b il a t e r a l p a l m op l a n t a r t r a n s g r e d i e n t k e r a t od e r m a 300294 300918 k e r a t o s i s f o lli c u l a r i s s p i nu l o s a d eca l v a n s , X - li nk e d k e r a t o s i s p il a r i s , p r og r e ss i v e c i ca t r i c i a l a l op ec i a o f t h e s ca l p , e y e b r o w s , a nd e y e l a s h e s 300294 308800 Z DHH C 8 Z i n c f i ng e r , DHH C - t yp e c on t a i n i ng 8 p a l m it oy l a ti on S c h i z oph r e n i a s u s ce p ti b ilit y h a ll u c i n a ti on s a nd d e l u s i on s , i n a pp r op r i a t e e m o ti on a l r e s pon s e s , d i s o r d e r e d t h i nk i ng a nd c on ce n t r a ti on , e rr a ti c b e h a v i o r 608784 181500 Z DHH C 9 Z i n c f i ng e r , DHH C - t yp e c on t a i n i ng 9 p a l m it oy l a ti on X - li nk e d m e n t a l r e t a r d a ti on ( R a y m ond t yp e ) g e n e r a l i n t e ll ec t u a l li m it a ti on s a ss o c i a t e d w it h i m p a i r m e n t s i n a d a p ti v e b e h a v i o r 300646 300799 Z D HH C 15 Z i n c f i ng e r , DHH C - t yp e c on t a i n i ng 15 p a l m it oy l a ti on X - li nk e d m e n t a l r e t a r d a ti on - 91 g e n e r a l i n t e ll ec t u a l l i m it a ti on s a ss o c i a t e d w it h i m p a i r m e n t s i n a d a p ti v e b e h a v i o r 300576 300577 PP T 1 P a l m it oy l - p r o t e i n t h i o e s t e r a s e 1 p a l m it oy l a ti on N e u r on a l ce r o i d li po f u s c i no s i s 1 H e t e r og e nou s : p r og r e ss i v e d e m e n ti a , s e i z u r e s , a nd p r og r e ss i v e v i s u a l d e f i c i e n c y . T h e ce ll u l a r ph e no t yp e i n c l ud e s i n t r ace ll u l a r acc u m u l a ti on o f a u t o f l uo r e s ce n t li pop i g m e n t s t o r a g e m a t e r i a l . 600722 256730 J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 745 COPII complex Sec23B is involved in the formation of COPII vesicles from the ER and has been lately identified deficient in 2009 by Schwarz and collaborators in congenital dyserythropoietic anemia type II ( CDAII ) also known as the hereditary erythro - blastic multinuclearity with a positive acidified - serum lysis test ( HEMPAS ) ( Schwarz et al 2009 ) . This autosomal reces - sive disorder is characterized by bi - and multinucleated eryth - roblasts . The biochemical characteristic of the disease was a sharper band 3 in the analysis of erythrocyte ghost extracts . This was the consequence of an impaired N - glycosylation of erythrocyte membrane proteins . The glycan structures were elucidated and showed the presence of immature oligosaccha - rides like high mannose , hybrid , and truncated complex type oligosaccharides ( Denecke et al 2008 ) . The expression of the defect only in the erythroid lineage is due to the expression levels of SEC23A and SEC23B genes . The SEC23A paralog is indeed expressed in all other tissues , except in erythroid cells . Golgin proteins Golgi microtubule associated protein 210 ( GMAP - 210 ) is encoded by the thyroid hormone receptor interactor 11 gene ( TRIP11 ) . This protein is a member of the Golgin family , proteins that capture vesicles carrying Rab proteins and main - tain the Golgi architecture ( Yu and Hughson 2010 ) . The N - terminal part of GMAP - 210 interacts with the curved mem - branes of the vesicles while its C - terminal domain interacts with flat Golgi membranes through interaction with the small guanine nucleotide binding protein Arf1 ( Drin et al 2008 ) . Fibroblasts and chondrocytes lacking GMAP - 210 presented modifications of proteoglycan glycosylation , with incomplete glycan structures terminated with N - acetylglucosamine ( GlcNAc ) residues . A specific retention of Perlecan in the endoplasmic reticulum has also been shown . The study also demonstrated that mutations in TRIP11 led to achondrogenesis type 1A , a lethal human disease character - ized by abnormal ossifications and distinctive histological fea - tures of the cartilage ( Smits et al 2010 ) . Defects in genes indirectly involved in glycosylation : defects in Golgi homeostasis Another growing class of identified defects affects Golgi homeostasis in terms of pH and or cations homeo - stasis . While the impact of such defects on Golgi glyco - sylation is still controversial , one could think that some specific Golgi glycosyltransferases are extremely sensible to pH / cations changes . E3 ubiquitin ligase UBE3A encodes the E3 ubiquitin ligase Ube3a , this gene is epigenetically imprinted throughout neuronal brain cells ( Chamberlain and Lalande 2010 ) . Ube3a attaches ubiquitin to diverse substrates and modifies the function and / or the turn - over of the ubiquitinylated proteins among which are a certain number of Golgi proteins . Angelman Syndrome is caused by mutations or deletions of the maternally inherited UBE3A gene , because the paternal allele of UBE3A is epige - netically silenced in neurons . The clinical features of the dis - ease consists of intellectual disability , lack of speech , seizures , and a characteristic behavioral profile . A recent study has demonstrated that the lack of ubiquitin protein ligase E3A increases the intraluminal Golgi pH with a concomitant reduc - tion in protein sialylation and a distended Golgi phenotype . The mechanism by which Ube3a regulates Golgi pH remains undetermined ( Condon et al 2013 ) . Interestingly , two other Golgi proteins ( ATP6V0A2 and TMEM165 ) have been linked to CDGs by impairing Golgi pH and or cation homeostasis . This has been extensively highlighted in recent reviews ( Jaeken 2011 ; Freeze 2013 ; Freeze et al 2014 ) . Acetylation Acetylation is an enzymatic reaction that consists in the sub - stitution of an active hydrogen atom by an acetyl group ( COCH 3 ) from the donor acetyl coenzyme A ( Ac - CoA ) ( Fig . 1 ) . The Ac - CoA is synthesized in the cytosol , then imported into the ER lumen for the subsequent acetylation reaction via SLC33A1 ( solute carrier family 33 ) , its specific transporter ( Hirabayashi et al 2013 ) . The way for Ac - CoA to reach the GA lumen is currently unknown since no Golgi specific Ac - CoA transporter has been identified ( Jonas et al 2010 ; Hirabayashi et al 2013 ) . A vesicular transport is how - ever not excluded . Two main types of acetylation have been identified at the Golgi level : the N - terminal acetylation of proteins and acetylation of specific monosaccharides ( Varki and Diaz 1985 ; Van Damme et al 2011 ; Yang et al 2011 ) . Concerning the N - terminal acetylation , only histone acetyl - transferase type B protein 4 ( HAT4 ) localizes in the GA mem - branes and has been shown to be specifically involved in the acetylation of free histone H4 at the cytoplasmic face of the GA ( Yang et al 2011 ) . At the opposite , sugar acetylation oc - curs in the lumen of Golgi . Sialic acids residues can for ex - ample be O - acetylated at the 4 , 7 , 8 , and / or 9 position ( Klein and Roussel 1998 ) by specific Golgi acetyl transferases ( Schauer 2004 ; Mandal et al 2012 ) . The exact physiological roles of O - acetylation of sialic acid however , remain to be fully elucidated . 746 J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 Defects in genes involved in acetylation No direct defects in Golgi acetyltransferases have been identified so far . Nevertheless , SLC33A1 has been shown to be mutated in patients from a Chinese population affected by autosomal dominant spastic paraplegia - 42 ( SPG42 ) ( Lin et al 2008 ; Mao et al 2015 ) . Although the molecular mechanisms leading to the pathology are not currently known , one can suggest that a global acetylation loss should be seen , as well as a specific loss of O - acetylated glycoconjugates at the Golgi level . Sulfation Sulfation is a common PTM only occurring in the Golgi lu - men ( Fig . 1 ) . This PTM is catalyzed by specific sulfotransferases and consists in a transfer of sulfate from the universal sulfate donor 3 ' - phosphoadenosine - 5 ' - phosphosulfate ( PAPS ) to the hydroxyl group of an acceptor ( a tyrosine on a protein or a sugar chain ) ( Kehoe and Bertozzi 2000 ; Honke and Taniguchi 2002 ; Yang et al 2015 ) . The im - port of PAPS in the Golgi lumen is facilitated by two Golgi - resident PAPS transporters , PAPST1 , and PAPST2 ( Kamiyama et al 2003 , 2006 ) . Defects in genes involved in sulfation Macular corneal dystrophy ( MCD ) type II , an autosomal recessive hereditary disease affecting the cornea , is known to be due to mutations in the promoter region of the corneal - specific sulfotransferase GlcNAc6ST ( CHST6 ) gene ( Honke and Taniguchi 2002 ) . These mutations abolish the expression of CHST6 only in corneal cells , leading to the formation of unsulfated keratan sulfate in the cornea ( Nakazawa et al 1984 ) . As a result , patients suffer from a progressive opacification of the cornea . Besides , some mutations on the coding region of CHST6 have been described in patients suf - fering from MCD type I ( Akama et al 2000 ) . Several other defects listed in the Table 1 have also been identified . Phosphorylation Phosphorylation is a largely distributed PTM and consists in the addition of a phosphate ( PO 43 − ) group to any acceptor molecule ( Fig . 1 ) . This modification is highly dynamic and reversible . At the cis - Golgi level , phosphorylation of mannose residues carried by newly synthesized lysosomal enzymes is a crucial step for their recognition by mannose - 6 - phosphate re - ceptors and their correct targeting to lysosomes ( Braulke and Bonifacino 2009 ; Coutinho et al 2012 ) . Phosphorylation at the Golgi level also occurs via FAM20C on secretory calcium - binding phosphoproteins ( SCPP ) family ( including casein ) and many secreted proteins involved in biomineralization , including the small integrin binding ligand N - linked glycopro - teins ( SIBLING proteins ) ( Nalbant et al 2005 ; Tagliabracci et al 2012 ) . While many different specific kinases are present within Golgi lumen , these enzymes are however poorly char - acterized . Finally , phosphorylation on the GA can take place on xylose residues carried by proteoglycans , via the action of FAM20B ( Koike et al 2009 ) . Defects in genes involved in phosphorylation Among other proteins , the mannose - 6 - phosphate pathway is composed of the GlcNAc - 1 - phosphotransferase and the uncovering enzyme , which are in charge of the phosphoryla - tion of mannose residues in the cis - Golgi ( Coutinho et al 2012 ) . GlcNAc - 1 - phosphotransferase deficiencies cause mucolipidosis II and III , two lysosomal storage diseases ( LSD ) which are characterized by missorting and cellular loss of lysosomal enzymes , and lysosomal accumulation of storage materials ( Tiede et al 2005 ) . Mucolipidosis II , also referred to as I - cell disease , is the most severe one and affected individ - uals most often die in early childhood ( Neufeld 1974 ; Cathey et al 2010 ) . Misrouting of lysosomal enzymes can cause nu - merous pathologies , including many LSD . Interestingly , a ge - netic linkage analysis has underlined the link between stuttering and mannose - 6 - phosphate pathway genes ( Kang and Drayna 2011 ) . The other phosphorylation identified de - fects are mentioned in Table 1 . Methylation Methylation is a form of alkylation where a methyl group replace a hydrogen atom ( Fig . 1 ) . With the exception of DNA methylation , protein methylation generally occurs on lysine residues and is not restricted to Golgi . At the Golgi level , methylation is an enzymatic PTM taking place at the cytosolic face of the organelle and using S - adenosylmethionine ( SAM ) as substrate . This modification generally occurs on N - terminal arginines of specific resident Golgi and cargo proteins ( Wu et al 2004a ; Zhou et al 2010 ) , except for calmodulin where the methylation ( trimethylation ) occurs on lysine 115 ( Magnani et al 2010 ; Magen et al 2012 ) . Interestingly , meth - ylation has been shown to be crucial in the maintenance of Golgi structure ( Zhou et al 2010 ) . Defects in genes involved in methylation Calmodulin can be trimethylated by calmodulin - lysine N - methyltransferase ( CAMKMT ) ( Magen et al 2012 ) . In normal individuals , there are two isoforms of CAMKMT : the first one is localized in the cytoplasm and the nucleus and the second one is strictly localized in Golgi . 2p21 deletion syndrome is caused by a homozygous deletion which includes SLC3A1 , PREPL , PPM1B , and the first exon of CAMKMT leading to a J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 747 loss of its expression ( Parvari et al 2005 ) . This syndrome consists of cystinuria , neonatal seizures , hypotonia , severe somatic and developmental delay , facial dysmorphism , and reduced activity of all the respiratory chain enzymatic com - plexes that are encoded in the mitochondria ( Parvari et al 2005 ) . Authors have demonstrated that the patients suffering from 2p21 deletion syndrome accumulate hypomethylated calmodulin in lysates from their lymphoblastoid cells ( Magen et al 2012 ) . As a result , there is still no way to know if calmodulin hypomethylation is due to a loss of the Golgi isoform . However , no direct defects in Golgi methylation have been reported to date . Palmitoylation Protein S - palmitoylation describes the covalent but reversible attachment of palmitate onto cysteine residues ( Fig . 1 ) . Palmitoylation is a highly dynamic PTM , catalyzed by palmitoyl acyltransferases ( PAT ) , that add the palmitate from palmitoyl - CoA anchored on membranes , and their counterpart the acyl protein thioesterases that remove the fatty acid ( Salaun et al 2010 ) . At the Golgi level , palmitoylation mainly takes place at the cytosolic trans face of the organelle . Interestingly , 12 of the 23 known human PAT localize in the Golgi ( Planey and Zacharias 2009 ) , making Golgi an emerg - ing center for peripheral membrane protein palmitoylation ( Salaun et al 2010 ) . Defects in genes involved in palmitoylation Palmitoylation deficiencies have been linked to several neuropsychiatric disorders ( Young et al 2012 ) . Zinc finger , DHHC domain like containing eight ( ZDHHC8 ) mutations have been clearly linked to schizophrenia ( Liu et al 2002 ) , ZDHHC15 loss and ZDHHC9 mutations have also been found in patients with X - linked mental retardation ( Mansouri et al 2005 ; Raymond et al 2007 ) . Moreover , muta - tions in palmitoyl - protein thioesterase 1 ( PPT1 ) gene lead to infantile neuronal ceroid lipofuscinosis , a well - described neu - rodegenerative phenotype in infants ( Vesa et al 1995 ) . Proteolytic cleavage Proteolytic processing is a PTM that occurs when a protease cleaves a target protein to modify its activity ( Fig . 1 ) . Several peptides ( i . e . , peptide hormones ) and proteins like growth fac - tors , transcription factors , plasma membrane receptors are synthesized as precursors and must undergo proteolytic cleav - age in Golgi lumen to be active ( Vey et al 1994 ) . Many Golgi endoproteases such as site 1 protease ( S1P ) , site 2 protease ( S2P ) and furin have been identified ( Wise et al 1990 ; Rawson et al 1997 ; Seidah et al 1999 ) . MBTPS2 is the gene encoding S2P , a Golgi membrane bound protease involved in cholesterol metabolism ( Rawson et al 1997 ) . S2P substrates in the Golgi includes SREBP transcription factors ( SREBP - 1a , SREBP 1 - c , and SREBP - 2 ) and other membrane bound transcription factors requiring a two step cleavage for activa - tion ( Rawson 2013 ) . Defects in genes involved in proteolytic cleavage Even if there is a real lack of data related to S2P in humans , MBTPS2 defects have been linked to several human X - linked skin diseases . MBTPS2 has been shown mutated in the Olmsted syndrome ( Haghighi et al 2013 ) , a rare keratinization disorder characterized by the combination of periorificial ker - atotic plaques and bilateral palmoplantar transgredient kerato - derma ( Yaghoobi et al 2007 ) . The second pathology linked to mutations in MBTPS2 is the IFAP ( ichthyosis follicularis with atrichia and photophobia ) syndrome ( Oeffner et al 2009 ; Ding et al 2010 ; Tang et al 2011 ) . Finally , MBTPS2 has also been linked to keratosis follicularis spinulosa decalvans ( KFSD ) disease ( Aten et al 2010 ) . Conclusion Apart from its cellular targeting roles , this review highlights Golgi as the main cellular factory for post - translational mod - ifications . We have seen that these modifications could be essential for the stability , activity , trafficking , and proper sub - cellular localization of many proteins . Several human different diseases due to genes directly involved in the biochemical reaction of post - translational modification have been reported . However and according to the huge number of proteins in - volved in the Golgi structure and function maintenance ( trans - porters / vesicular proteins ( Rabs , tethering factors , SNAREs , complex associated proteins ) / microtubule associated proteins / structural proteins ) , there are no doubts that the integrity of many different PTM is affected . The current lack of tools to explore the different PTM as well as the unavailability of the tissue for clinical testing ( i . e . , nervous system ) complicates such analysis . Acknowledgments We would like to dedicate this work to our col - league and friend Pr . Christian Körner who suddenly passed away early in January . The work was supported by a grant from the grant ERARE 11 – 135 ( EURO - CDG ) of the ERA - Net for Research Programmes on Rare Diseases Joint Transnational Call 2011 to F . F . Compliance with Ethics Guidelines Conflict of Interest None . Animal rights This article does not contain any studies with human or animal subjects performed by the any of the authors . 748 J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 References Akama TO , Nishida K , Nakayama J et al ( 2000 ) Macular corneal dystro - phy type I and type II are caused by distinct mutations in a new sulphotransferase gene . Nat Genet 26 : 237 – 241 . doi : 10 . 1038 / 79987 Aten E , Brasz LC , Bornholdt D et al ( 2010 ) Keratosis follicularis spinulosa decalvans is caused by mutations in MBTPS2 . Hum Mutat 31 : 1125 – 1133 . doi : 10 . 1002 / humu . 21335 Braulke T , Bonifacino JS ( 2009 ) Sorting of lysosomal proteins . Biochim Biophys Acta 1793 : 605 – 614 . doi : 10 . 1016 / j . bbamcr . 2008 . 10 . 016 Carchon HA , Ndosimao CN , Aerschot SV , Jaeken J ( 2006 ) Use of serum on guthrie cards in screening for congenital disorders of glycosyla - tion . Clin Chem 52 : 774 – 775 . doi : 10 . 1373 / clinchem . 2005 . 063305 Cathey SS , Leroy JG , Wood T et al ( 2010 ) Phenotype and genotype in mucolipidoses II and III alpha / beta : a study of 61 probands . J Med Genet 47 : 38 – 48 . doi : 10 . 1136 / jmg . 2009 . 067736 Chamberlain SJ , Lalande M ( 2010 ) Angelman syndrome , a genomic imprinting disorder of the brain . J Neurosci Off J Soc Neurosci 30 : 9958 – 9963 . doi : 10 . 1523 / JNEUROSCI . 1728 - 10 . 2010 Condon KH , Ho J , Robinson CG et al ( 2013 ) The Angelman syndrome protein Ube3a / E6AP is required for Golgi acidification and surface protein sialylation . J Neurosci Off J Soc Neurosci 33 : 3799 – 3814 . doi : 10 . 1523 / JNEUROSCI . 1930 - 11 . 2013 Coutinho MF , Prata MJ , Alves S ( 2012 ) Mannose - 6 - phosphate pathway : a review on its role in lysosomal function and dysfunction . Mol Genet Metab 105 : 542 – 550 . doi : 10 . 1016 / j . ymgme . 2011 . 12 . 012 CylwikB , LipartowskaK , Chrostek L , GruszewskaE ( 2013a ) Congenital disorders of glycosylation . Part II . Defects of protein O - glycosyla - tion . Acta Biochim Pol 60 : 361 – 368 Cylwik B , Naklicki M , Chrostek L , Gruszewska E ( 2013b ) Congenital disorders of glycosylation . Part I . Defects of protein N - glycosyla - tion . Acta Biochim Pol 60 : 151 – 161 Denecke J , Kranz C , Nimtz M et al ( 2008 ) Characterization of the N - glycosylation phenotype of erythrocyte membrane proteins in con - genital dyserythropoietic anemia type II ( CDA II / HEMPAS ) . Glycoconj J 25 : 375 – 382 . doi : 10 . 1007 / s10719 - 007 - 9089 - 1 Ding YG , Wang JY , Qiao JJ et al ( 2010 ) A novel mutation in MBTPS2 causes ichthyosis follicularis , alopecia and photophobia ( IFAP ) syn - drome in a Chinese family . Br J Dermatol 163 : 886 – 889 . doi : 10 . 1111 / j . 1365 - 2133 . 2010 . 09890 . x Drin G , Morello V , Casella J - F et al ( 2008 ) Asymmetric tethering of flat and curved lipid membranes by a golgin . Science 320 : 670 – 673 . doi : 10 . 1126 / science . 1155821 Dunphy WG , Rothman JE ( 1985 ) Compartmental organization of the Golgi stack . Cell 42 : 13 – 21 Edvardson S , Ashikov A , Jalas C et al ( 2013 ) Mutations in SLC35A3 cause autism spectrum disorder , epilepsy and arthrogryposis . J Med Genet 50 : 733 – 739 . doi : 10 . 1136 / jmedgenet - 2013 - 101753 Farquhar MG ( 1985 ) Progress in unraveling pathways of Golgi traffic . Annu Rev Cell Biol 1 : 447 – 488 . doi : 10 . 1146 / annurev . cb . 01 . 110185 . 002311 Foulquier F ( 2009 ) COG defects , birth and rise ! Biochim Biophys Acta 1792 : 896 – 902 . doi : 10 . 1016 / j . bbadis . 2008 . 10 . 020 Foulquier F , Vasile E , Schollen E et al ( 2006 ) Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II . Proc Natl Acad Sci U S A 103 : 3764 – 3769 . doi : 10 . 1073 / pnas . 0507685103 Foulquier F , Ungar D , Reynders E et al ( 2007 ) A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1 - Cog8 interaction in COG complex formation . Hum Mol Genet 16 : 717 – 730 . doi : 10 . 1093 / hmg / ddl476 Freeze HH ( 2013 ) Understanding human glycosylation disorders : bio - chemistry leads the charge . J Biol Chem 288 : 6936 – 6945 . doi : 10 . 1074 / jbc . R112 . 429274 Freeze HH , Chong JX , Bamshad MJ , Ng BG ( 2014 ) Solving glycosyla - tion disorders : fundamental approaches reveal complicated path - ways . Am J Hum Genet 94 : 161 – 175 . doi : 10 . 1016 / j . ajhg . 2013 . 10 . 024 Glick BS , Luini A ( 2011 ) Models for Golgi traffic : a critical assessment . Cold Spring Harb Perspect Biol 3 : a005215 . doi : 10 . 1101 / cshperspect . a005215 Hackler R , Arndt T , Helwig - Rolig A et al ( 2000 ) Investigation by iso - electric focusing of the initial carbohydrate - deficient transferrin ( CDT ) and non - CDT transferrin isoform fractionation step involved in determination of CDT by the ChronAlcoI . D . assay . Clin Chem 46 : 483 – 492 Haghighi A , Scott CA , Poon DS et al ( 2013 ) A missense mutation in the MBTPS2 gene underlies the X - linked form of Olmsted syndrome . J Investig Dermatol 133 : 571 – 573 . doi : 10 . 1038 / jid . 2012 . 289 Hennet T ( 2012 ) Diseases of glycosylation beyond classical congenital disorders of glycosylation . Biochim Biophys Acta 1820 : 1306 – 1317 . doi : 10 . 1016 / j . bbagen . 2012 . 02 . 001 Hirabayashi Y , Nomura KH , Nomura K ( 2013 ) The acetyl - CoA trans - porter family SLC33 . Mol Aspects Med 34 : 586 – 589 . doi : 10 . 1016 / j . mam . 2012 . 05 . 009 Honke K , Taniguchi N ( 2002 ) Sulfotransferases and sulfated oligosac - charides . Med Res Rev 22 : 637 – 654 . doi : 10 . 1002 / med . 10020 Jaeken J ( 2011 ) Congenital disorders of glycosylation ( CDG ) : it ’ s ( nearly ) all in it ! J Inherit Metab Dis 34 : 853 – 858 . doi : 10 . 1007 / s10545 - 011 - 9299 - 3 Jaeken J , Matthijs G ( 2001 ) Congenital disorders of glycosylation . Annu Rev Genomics Hum Genet 2 : 129 – 151 . doi : 10 . 1146 / annurev . genom . 2 . 1 . 129 Jonas MC , Pehar M , Puglielli L ( 2010 ) AT - 1 is the ER membrane acetyl - CoA transporter and is essential for cell viability . J Cell Sci 123 : 3378 – 3388 . doi : 10 . 1242 / jcs . 068841 Kamiyama S , Suda T , Ueda R et al ( 2003 ) Molecular cloning and iden - tification of 3 ’ - phosphoadenosine 5 ’ - phosphosulfate transporter . J Biol Chem 278 : 25958 – 25963 . doi : 10 . 1074 / jbc . M302439200 Kamiyama S , Sasaki N , Goda E et al ( 2006 ) Molecular cloning and characterization of a novel 3 ’ - phosphoadenosine 5 ’ - phosphosulfate transporter , PAPST2 . J Biol Chem 281 : 10945 – 10953 . doi : 10 . 1074 / jbc . M508991200 Kang C , Drayna D ( 2011 ) Genetics of speech and language disorders . Annu Rev Genomics Hum Genet 12 : 145 – 164 . doi : 10 . 1146 / annurev - genom - 090810 - 183119 Kehoe JW , Bertozzi CR ( 2000 ) Tyrosine sulfation : a modulator of extra - cellular protein - protein interactions . Chem Biol 7 : R57 – R61 Klein A , Roussel P ( 1998 ) O - Acetylation of sialic acids . Biochimie 80 : 49 – 57 . doi : 10 . 1016 / S0300 - 9084 ( 98 ) 80056 - 4 Kodera H , Nakamura K , Osaka H et al ( 2013 ) De novo mutations in SLC35A2 encoding a UDP - galactose transporter cause early - onset epileptic encephalopathy . Hum Mutat 34 : 1708 – 1714 . doi : 10 . 1002 / humu . 22446 Kodera H , Ando N , Yuasa I et al ( 2014 ) Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congen - ital disorder of glycosylation . Clin Genet . doi : 10 . 1111 / cge . 12417 Koike T , Izumikawa T , Tamura J - I , Kitagawa H ( 2009 ) FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan - protein linkage region . Biochem J 421 : 157 – 162 . doi : 10 . 1042 / BJ20090474 Kranz C , Ng BG , Sun L et al ( 2007 ) COG8 deficiency causes new con - genital disorder of glycosylation type IIh . Hum Mol Genet 16 : 731 – 741 . doi : 10 . 1093 / hmg / ddm028 Krasnewich D ( 2014 ) Human glycosylation disorders . Cancer Biomarkers Sect Dis Markers 14 : 3 – 16 . doi : 10 . 3233 / CBM - 130374 Lin P , Li J , Liu Q et al ( 2008 ) A missense mutation in SLC33A1 , which encodes the acetyl - CoA transporter , causes autosomal - dominant spastic paraplegia ( SPG42 ) . Am J Hum Genet 83 : 752 – 759 . doi : 10 . 1016 / j . ajhg . 2008 . 11 . 003 J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 749 Liu H , Abecasis GR , Heath SCetal ( 2002 ) Geneticvariation in the22q11 locus and susceptibility to schizophrenia . Proc Natl Acad Sci U S A 99 : 16859 – 16864 . doi : 10 . 1073 / pnas . 232186099 Lübbehusen J , Thiel C , Rind N et al ( 2010 ) Fatal outcome due to defi - ciency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation . Hum Mol Genet 19 : 3623 – 3633 . doi : 10 . 1093 / hmg / ddq278 Magen S , Magnani R , Haziza S et al ( 2012 ) Human calmodulin methyl - transferase : expression , activity on calmodulin , and Hsp90 depen - dence . PLoS One 7 , e52425 . doi : 10 . 1371 / journal . pone . 0052425 Magnani R , Dirk LMA , Trievel RC , Houtz RL ( 2010 ) Calmodulin meth - yltransferase is an evolutionarily conserved enzyme that trimethylates Lys - 115 in calmodulin . Nat Commun 1 : 43 . doi : 10 . 1038 / ncomms1044 Mandal C , Mandal C , Chandra S et al ( 2012 ) Regulation of O - acetylation of sialic acids by sialate - O - acetyltransferase and sialate - O - acetylesterase activities in childhood acute lymphoblastic leukemia . Glycobiology 22 : 70 – 83 . doi : 10 . 1093 / glycob / cwr106 Mansouri MR , Marklund L , Gustavsson P et al ( 2005 ) Loss of ZDHHC15 expression in a woman with a balanced translocation t ( X ; 15 ) ( q13 . 3 ; cen ) and severe mental retardation . Eur J Hum Genet EJHG 13 : 970 – 977 . doi : 10 . 1038 / sj . ejhg . 5201445 Mao F , Li Z , ZhaoB etal ( 2015 ) IdentificationandFunctionalAnalysis of a SLC33A1 : c . 339 T > G ( p . Ser113Arg ) Variant in the Original SPG42 Family . Hum Mutat 36 : 240 – 249 . doi : 10 . 1002 / humu . 22732 Miller VJ , Ungar D ( 2012 ) Re ’ COG ’ nition at the Golgi . Traffic Cph Den 13 : 891 – 897 . doi : 10 . 1111 / j . 1600 - 0854 . 2012 . 01338 . x Mohamed M , Ashikov A , Guillard M et al ( 2013 ) Intellectual disability and bleeding diathesis due to deficient CMP – sialic acid transport . Neurology 81 : 681 – 687 . doi : 10 . 1212 / WNL . 0b013e3182a08f53 Mollenhauer HH , Morré DJ ( 1974 ) Polyribosomes associated with the Golgi apparatus . Protoplasma 79 : 333 – 336 Nakazawa K , Hassell JR , Hascall VC etal ( 1984 ) Defectiveprocessing of keratan sulfate in macular corneal dystrophy . J Biol Chem 259 : 13751 – 13757 Nalbant D , Youn H , Nalbant SI et al ( 2005 ) FAM20 : an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells . BMC Genomics 6 : 11 . doi : 10 . 1186 / 1471 - 2164 - 6 - 11 Neufeld EF ( 1974 ) The biochemical basis for mucopolysaccharidoses and mucolipidoses . Prog Med Genet 10 : 81 – 101 Ng BG , Kranz C , Hagebeuk EEO et al ( 2007 ) Molecular and clinical characterization of a Moroccan Cog7 deficient patient . Mol Genet Metab 91 : 201 – 204 . doi : 10 . 1016 / j . ymgme . 2007 . 02 . 011 Ng BG , Buckingham KJ , Raymond K et al ( 2013 ) Mosaicism of the UDP - galactose transporter SLC35A2 causes a congenital disorder of glycosylation . Am J Hum Genet 92 : 632 – 636 . doi : 10 . 1016 / j . ajhg . 2013 . 03 . 012 Oeffner F , Fischer G , Happle R et al ( 2009 ) IFAP syndrome is caused by deficiency in MBTPS2 , an intramembrane zinc metalloprotease es - sential for cholesterol homeostasis and ER stress response . Am J Hum Genet 84 : 459 – 467 . doi : 10 . 1016 / j . ajhg . 2009 . 03 . 014 Paesold - Burda P , Maag C , Troxler H et al ( 2009 ) Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation . Hum Mol Genet 18 : 4350 – 4356 . doi : 10 . 1093 / hmg / ddp389 Parvari R , Gonen Y , Alshafee I et al ( 2005 ) The 2p21 deletion syndrome : characterization of the transcription content . Genomics 86 : 195 – 211 . doi : 10 . 1016 / j . ygeno . 2005 . 04 . 001 Planey SL , Zacharias DA ( 2009 ) Palmitoyl acyltransferases , their sub - strates , and novel assays to connect them ( Review ) . Mol Membr Biol 26 : 14 – 31 . doi : 10 . 1080 / 09687680802646703 Rawson RB ( 2013 ) The site - 2 protease . Biochim Biophys Acta 1828 : 2801 – 2807 . doi : 10 . 1016 / j . bbamem . 2013 . 03 . 031 Rawson RB , Zelenski NG , Nijhawan D et al ( 1997 ) Complementation cloning of S2P , a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs . Mol Cell 1 : 47 – 57 Raymond FL , Tarpey PS , Edkins S et al ( 2007 ) Mutations in ZDHHC9 , which encodes a palmitoyltransferase of NRAS and HRAS , cause X - linked mental retardation associated with a Marfanoid habitus . Am J Hum Genet 80 : 982 – 987 . doi : 10 . 1086 / 513609 Reynders E , Foulquier F , Leão Teles E et al ( 2009 ) Golgi function and dysfunction in the first COG4 - deficient CDG type II patient . Hum Mol Genet 18 : 3244 – 3256 . doi : 10 . 1093 / hmg / ddp262 Reynders E , Foulquier F , Annaert W , Matthijs G ( 2011 ) How Golgi glycosylation meets and needs trafficking : the case of the COG complex . Glycobiology 21 : 853 – 863 . doi : 10 . 1093 / glycob / cwq179 Riemersma M , Sandrock J , Boltje TJ et al ( 2014 ) Disease mutations in CMP - sialic acid transporter SLC35A1 result in abnormal α - dystroglycan O - mannosylation , independent from sialic acid . Hum Mol Genet . doi : 10 . 1093 / hmg / ddu742 Rosnoblet C , Peanne R , Legrand D , Foulquier F ( 2013 ) Glycosylation disorders of membrane trafficking . Glycoconj J 30 : 23 – 31 . doi : 10 . 1007 / s10719 - 012 - 9389 - y Roth J ( 2002 ) Protein N - glycosylation along the secretory pathway : rela - tionship to organelle topography and function , protein quality con - trol , and cell interactions . Chem Rev 102 : 285 – 303 Roth J , Zuber C , Park S et al ( 2010 ) Protein N - glycosylation , protein folding , and protein quality control . Mol Cell 30 : 497 – 506 . doi : 10 . 1007 / s10059 - 010 - 0159 - z Rymen D , Peanne R , Millón MB et al ( 2013 ) MAN1B1 deficiency : an unexpected CDG - II . PLoS Genet 9 , e1003989 . doi : 10 . 1371 / journal . pgen . 1003989 Salaun C , Greaves J , Chamberlain LH ( 2010 ) The intracellular dynamic of protein palmitoylation . J Cell Biol 191 : 1229 – 1238 . doi : 10 . 1083 / jcb . 201008160 Schauer R ( 2004 ) Sialic acids : fascinating sugars in higher animals and man . Zool Jena Ger 107 : 49 – 64 . doi : 10 . 1016 / j . zool . 2003 . 10 . 002 Schwarz K , Iolascon A , Verissimo F et al ( 2009 ) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II . Nat Genet 41 : 936 – 940 . doi : 10 . 1038 / ng . 405 Scott K , Gadomski T , Kozicz T , Morava E ( 2014 ) Congenital disorders of glycosylation : new defects andstillcounting . J Inherit Metab Dis37 : 609 – 617 . doi : 10 . 1007 / s10545 - 014 - 9720 - 9 Seidah NG , Mowla SJ , Hamelin J et al ( 1999 ) Mammalian subtilisin / kexin isozyme SKI - 1 : a widely expressed proprotein convertase with a unique cleavage specificity and cellular localization . Proc Natl Acad Sci U S A 96 : 1321 – 1326 Smits P , Bolton AD , Funari V et al ( 2010 ) Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP - 210 . N Engl J Med 362 : 206 – 216 . doi : 10 . 1056 / NEJMoa0900158 Stanley P ( 2011 ) Golgi glycosylation . Cold Spring Harb Perspect Biol . doi : 10 . 1101 / cshperspect . a005199 Tagliabracci VS , Engel JL , Wen J et al ( 2012 ) Secreted kinase phosphor - ylates extracellular proteins that regulate biomineralization . Science 336 : 1150 – 1153 . doi : 10 . 1126 / science . 1217817 Tang L , Liang J , Wang W et al ( 2011 ) A novel mutation in MBTPS2 causes a broad phenotypic spectrum of ichthyosis follicularis , atrichia , and photophobia syndrome in a large Chinese family . J Am Acad Dermatol 64 : 716 – 722 . doi : 10 . 1016 / j . jaad . 2010 . 02 . 045 Tiede S , Storch S , Lübke T et al ( 2005 ) Mucolipidosis II is caused by mutations in GNPTA encoding the alpha / beta GlcNAc - 1 - phospho - transferase . Nat Med 11 : 1109 – 1112 . doi : 10 . 1038 / nm1305 Van Damme P , Hole K , Pimenta - Marques A et al ( 2011 ) NatF contributes to an evolutionary shift in protein N - terminal acetylation and is important for normal chromosome segregation . PLoS Genet 7 , e1002169 . doi : 10 . 1371 / journal . pgen . 1002169 Van Scherpenzeel M , Timal S , Rymen D et al ( 2014 ) Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency . Brain J Neurol 137 : 1030 – 1038 . doi : 10 . 1093 / brain / awu019 750 J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 Varki A , Diaz S ( 1985 ) The transport and utilization of acetyl coenzyme A by rat liver Golgi vesicles . J Biol Chem 260 : 6600 – 6608 Vesa J , Hellsten E , Verkruyse LA et al ( 1995 ) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis . Nature 376 : 584 – 587 . doi : 10 . 1038 / 376584a0 Vey M , Schäfer W , Berghöfer S et al ( 1994 ) Maturation of the trans - Golgi network protease furin : compartmentalization of propeptide remov - al , substrate cleavage , and COOH - terminal truncation . J Cell Biol 127 : 1829 – 1842 Wise RJ , Barr PJ , Wong PA et al ( 1990 ) Expression of a human proprotein processing enzyme : correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site . Proc Natl Acad Sci U S A 87 : 9378 – 9382 Wu CC , MacCoss MJ , Mardones G et al ( 2004a ) Organellar proteomics reveals Golgi arginine dimethylation . Mol Biol Cell 15 : 2907 – 2919 . doi : 10 . 1091 / mbc . E04 - 02 - 0101 Wu X , Steet RA , Bohorov O et al ( 2004b ) Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder . Nat Med 10 : 518 – 523 . doi : 10 . 1038 / nm1041 Yaghoobi R , Omidian M , Sina N et al ( 2007 ) Olmsted syndrome in an Iranian family : report of two new cases . Arch Iran Med 10 : 246 – 249 Yang X , Yu W , Shi L et al ( 2011 ) HAT4 , a Golgi apparatus - anchored B - type histone acetyltransferase , acetylates free histone H4 and facili - tates chromatin assembly . Mol Cell 44 : 39 – 50 . doi : 10 . 1016 / j . molcel . 2011 . 07 . 032 Yang Y - S , Wang C - C , Chen B - H et al ( 2015 ) Tyrosine sulfation as a protein post - translational modification . Mol Basel Switz 20 : 2138 – 2164 . doi : 10 . 3390 / molecules20022138 Young FB , Butland SL , Sanders SS et al ( 2012 ) Putting proteins in their place : palmitoylation in Huntington disease and other neuropsychi - atric diseases . Prog Neurobiol 97 : 220 – 238 . doi : 10 . 1016 / j . pneurobio . 2011 . 11 . 002 Yu I - M , Hughson FM ( 2010 ) Tethering factors as organizers of intracel - lular vesicular traffic . Annu Rev Cell Dev Biol 26 : 137 – 156 . doi : 10 . 1146 / annurev . cellbio . 042308 . 113327 Zhou Z , Sun X , Zou Z et al ( 2010 ) PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130 . Cell Res 20 : 1023 – 1033 . doi : 10 . 1038 / cr . 2010 . 56 J Inherit Metab Dis ( 2015 ) 38 : 741 – 751 751